![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Pharma Blog Watch
Pharma Blog Watch
October 4, 2006
Ketek Safety Warning
(Drug Injury Watch)
In his blog, Tom Lamb reports on a "Dear Doctor" letter sent by sanofi-aventis
in Canada about the safety, specifically involving "severe and sometimes
fatal hepatotoxicity," of its antibiotic Ketek based on postmarket adverse
event reports.
"In some of these cases liver injury occurred after administration of only a few doses of KETEK and progressed rapidly. The mechanism underlying severe hepatocellular injury is unknown," the letter says.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct